Cargando…
Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts
Integrase inhibitors (INSTIs) are recommended by expert panels as initial therapy for people with HIV. Because there can be disparities in prescribing and uptake of novel and/or recommended therapies, this analysis assessed potential INSTI prescribing disparities using a combined data set from the J...
Autores principales: | Monroe, Anne K, Levy, Matthew E, Greenberg, Alan E, Keruly, Jeanne C, Moore, Richard D, Horberg, Michael A, Kulie, Paige, Mohanraj, Bernadine S, Kumar, Princy N, Castel, Amanda D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496514/ https://www.ncbi.nlm.nih.gov/pubmed/34631925 http://dx.doi.org/10.1093/ofid/ofab338 |
Ejemplares similares
-
2492. Differences between Individuals Currently Taking Integrase Inhibitor (INSTI)-based Therapy and Those Not Taking INSTIs in the Era of INSTIs as Recommended First-line Therapy
por: Monroe, Anne K, et al.
Publicado: (2019) -
Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort
por: Koay, Wei Li A, et al.
Publicado: (2021) -
Identifying Geographic Areas of Washington, DC, With Increased Potential for Sexual HIV Transmission Among People With HIV With STIs and Concurrent Elevated HIV RNA: Data From the DC Cohort
por: Byrne, Morgan, et al.
Publicado: (2022) -
Psychosocial impacts of the COVID-19 pandemic from a cross-sectional Survey of people living with HIV in Washington, DC
por: Monroe, Anne K., et al.
Publicado: (2023) -
Johns Hopkins Hospital
Publicado: (1914)